How Peptide Hormones Are Made: Gene to Secretion

Peptide Hormones

3 processing steps

Every peptide hormone passes through the same three-step maturation: signal peptide removal in the ER, prohormone cleavage by convertases, and storage in secretory granules awaiting a release signal.

Seidah and Chrétien, Brain Research, 1999

Seidah and Chrétien, Brain Research, 1999

View as image

Every peptide hormone in your body, from insulin to oxytocin to GLP-1, follows the same fundamental production pathway. A gene encodes a large inactive precursor protein. That precursor gets threaded into the endoplasmic reticulum, trimmed, folded, packed into vesicles, cleaved by specialized enzymes, and stored in secretory granules until a signal triggers release. This multi-step assembly line ensures that active hormones are produced only in the right cells, stored safely in inactive form, and released precisely when needed. Understanding this pathway explains why peptide hormones cannot simply be taken as pills, why prohormone processing defects cause disease, and why pharmaceutical peptide production is so technically demanding. For the broader context of what peptide hormones do once released, see our pillar article on peptide hormones as signaling molecules.

Step 1: gene to preprohormone

Peptide hormone genes encode a precursor protein called a preprohormone. "Pre" refers to the signal peptide at the N-terminus. "Pro" refers to additional sequences that must be removed before the hormone becomes active. The preprohormone is the initial translation product of the mRNA on ribosomes.

The signal peptide is a stretch of 15-30 hydrophobic amino acids at the very beginning of the protein. As translation proceeds, the signal peptide emerges from the ribosome and is recognized by the signal recognition particle (SRP), which directs the entire ribosome-mRNA complex to the rough endoplasmic reticulum membrane. The growing polypeptide chain is fed through a translocon channel directly into the ER lumen.

Once inside the ER lumen, a signal peptidase enzyme immediately cleaves off the signal peptide. The remaining protein, now called a prohormone, is no longer "pre." This first processing step is co-translational, meaning it happens while the protein is still being synthesized.

Example: proinsulin. The insulin gene encodes preproinsulin (110 amino acids). Signal peptidase removes the 24-amino-acid signal peptide in the ER, yielding proinsulin (86 amino acids). Proinsulin still contains the B chain, C-peptide, and A chain as one continuous polypeptide that must be further processed.

Step 2: folding and quality control in the ER

Inside the ER lumen, the prohormone undergoes folding with the help of chaperone proteins. For hormones that contain disulfide bonds (like insulin, which has three), the ER's oxidizing environment enables correct disulfide bond formation. Proinsulin's three disulfide bonds form at this stage, locking the A and B chains into their final configuration while the C-peptide connecting segment keeps everything together.

The ER also performs quality control. Misfolded prohormones are recognized by the ER-associated degradation (ERAD) pathway and destroyed. Only correctly folded prohormones progress to the Golgi apparatus. This quality filter is essential: releasing a misfolded hormone would be worse than releasing none at all.

Some prohormones undergo glycosylation (sugar attachment) in the ER, adding carbohydrate chains that influence folding, stability, and receptor recognition. Not all peptide hormones are glycosylated, but those that are (like FSH and LH) require this modification for full biological activity.

Step 3: Golgi sorting and granule packaging

From the ER, prohormones travel to the Golgi apparatus in transport vesicles. The Golgi serves as the cell's sorting and packaging center. Here, prohormones are directed into one of two pathways:

Constitutive secretion: Continuous, unregulated release. Most non-endocrine cells use this pathway for proteins they secrete constantly. Peptide hormones generally do NOT use this pathway.

Regulated secretion: Prohormones are sorted into immature secretory granules that bud from the trans-Golgi network. These granules mature, acidify, and concentrate their contents. Mature secretory granules are stored in the cytoplasm, waiting for a release signal. This is the pathway peptide hormones use.

The sorting signal that directs prohormones into the regulated pathway is still being characterized, but it likely involves aggregation of prohormone molecules at the slightly acidic pH of the trans-Golgi (pH ~6.0-6.5). Many prohormones aggregate at this pH, forming dense cores that are selectively packaged into regulated secretory granules.

Step 4: prohormone cleavage by convertases

The most critical processing step occurs inside the maturing secretory granule. Prohormone convertases (PCs) cleave the prohormone at specific sites to release the active hormone.

The two dominant convertases in endocrine cells are PC1/3 and PC2. Both are serine proteases that recognize paired basic amino acid residues, typically Lys-Arg or Arg-Arg motifs, as cleavage signals. Different endocrine cells express different ratios of PC1/3 and PC2, which determines which products are generated from the same prohormone.

Proinsulin processing: PC1/3 and PC2 cleave proinsulin at two sites, releasing the C-peptide and producing the A and B chains of mature insulin, which remain connected by their preformed disulfide bonds. Equimolar amounts of insulin and C-peptide are released together, which is why C-peptide measurement reveals endogenous insulin production.

Proopiomelanocortin (POMC) processing: The same 241-amino-acid precursor produces different hormones in different tissues. In the anterior pituitary (which expresses primarily PC1/3), POMC yields ACTH and beta-lipotropin. In the intermediate lobe (which expresses PC2), ACTH is further cleaved into alpha-MSH and CLIP. Same gene, different convertases, different hormones.

Pro-glucagon processing: In pancreatic alpha cells (PC2-dominant), proglucagon yields glucagon. In intestinal L-cells (PC1/3-dominant), the same precursor yields GLP-1 and GLP-2. This tissue-specific processing from a single gene product is a recurring theme in peptide endocrinology.

Step 5: post-cleavage modifications

After convertase cleavage, additional enzymes perform finishing modifications:

Carboxypeptidase E (CPE) removes the trailing basic residues (Arg, Lys) left at the C-terminus after convertase cleavage. Without CPE activity, the hormone retains these extra amino acids and may have reduced receptor binding.

Peptidylglycine alpha-amidating monooxygenase (PAM) converts a C-terminal glycine into an amide group on many bioactive peptides. Approximately half of all known peptide hormones are C-terminally amidated. Amidation protects against exopeptidase degradation and is often required for full receptor activation. GnRH, TRH, calcitonin, and oxytocin all require amidation for biological activity.

Acetylation, phosphorylation, and sulfation occur on specific peptide hormones and can modulate their activity, receptor affinity, or half-life.

Step 6: regulated secretion

Mature secretory granules containing processed, active peptide hormones accumulate in the cytoplasm near the plasma membrane. They remain stored until a secretion signal arrives.

The trigger for regulated secretion varies by cell type but typically involves an increase in intracellular calcium concentration. In pancreatic beta cells, glucose metabolism raises ATP levels, which closes K-ATP channels, depolarizes the membrane, opens voltage-gated calcium channels, and drives calcium-dependent exocytosis of insulin-containing granules.

Other secretion triggers include cAMP elevation (used by many pituitary hormones), receptor-activated calcium release (used by GnRH-stimulated LH secretion), and direct neural stimulation (used by oxytocin release from hypothalamic neurons).

Exocytosis is the final step: the secretory granule membrane fuses with the plasma membrane, and the hormone (along with C-peptide, convertase fragments, and any other granule contents) is released into the extracellular space and enters the bloodstream.

Why this pathway matters for peptide pharmacology

Understanding biosynthesis explains several practical features of peptide therapeutics:

Why peptides can't be taken orally (usually). Peptide hormones are proteins. Stomach acid and digestive enzymes (the same pepsin that liberates lactoferricin from lactoferrin) degrade them before absorption. GLP-1 survives less than 2 minutes in circulation even when injected. Oral delivery requires specialized formulations that protect the peptide through the GI tract. For more on this challenge, see our sibling article on why peptide hormones can't be taken as pills.

Why recombinant insulin works. Pharmaceutical insulin is produced in bacteria or yeast that express the human insulin gene. The recombinant proinsulin is then processed in vitro (using enzymes that mimic PC1/3 and PC2) to produce correctly folded, disulfide-bonded insulin identical to the human product.

Why processing defects cause disease. Mutations in PC1/3 cause severe childhood obesity, adrenal insufficiency, and malabsorptive diarrhea because multiple prohormones (proinsulin, POMC, pro-GLP-1) fail to be processed into their active forms.

Why peptide vs steroid hormones require different approaches. Steroid hormones are small lipophilic molecules synthesized through enzymatic modification of cholesterol. They cross cell membranes freely. Peptide hormones are large, hydrophilic, and cannot cross membranes, requiring surface G-protein coupled receptors to transmit their signal. For the full comparison, see our sibling article on peptide vs steroid hormones.

The Bottom Line

Peptide hormone production follows a conserved six-step pathway: gene transcription to preprohormone, signal peptide removal in the ER, folding and quality control, Golgi sorting into regulated secretory granules, prohormone cleavage by convertases PC1/3 and PC2, and stimulus-dependent exocytosis. The same prohormone can generate different active hormones in different tissues depending on which convertases are expressed, as demonstrated by proglucagon yielding glucagon in alpha cells but GLP-1 in L-cells. This pathway's complexity explains why peptide drugs require injection, why processing defects cause multi-system disease, and why pharmaceutical peptide production demands precise enzymatic and chemical engineering.

Frequently Asked Questions

How are peptide hormones synthesized in the body?

Peptide hormones are synthesized as inactive precursors called preprohormones on ribosomes attached to the rough endoplasmic reticulum. The signal peptide directs the protein into the ER lumen where it is cleaved off. The resulting prohormone folds, travels through the Golgi, and is packaged into secretory granules. Inside the granules, prohormone convertases cleave it into the active hormone, which is stored until a calcium signal triggers release.

What is the difference between a preprohormone and a prohormone?

A preprohormone is the initial protein produced by the ribosome. It contains a signal peptide (the "pre" portion) plus the prohormone sequence. The signal peptide is removed in the endoplasmic reticulum, converting it into a prohormone. The prohormone still contains extra sequences that must be cleaved by convertases to produce the final active hormone.

What are prohormone convertases?

Prohormone convertases PC1/3 and PC2 are enzymes inside secretory granules that cleave prohormones at paired basic amino acid sites (Lys-Arg or Arg-Arg) to release active hormones. Different cells express different convertases, which is how the same prohormone produces different hormones in different tissues. For example, proglucagon yields glucagon in alpha cells (PC2) but GLP-1 in L-cells (PC1/3).

Why can't peptide hormones be taken as pills?

Peptide hormones are proteins that get destroyed by stomach acid and digestive enzymes (proteases) before they can be absorbed into the bloodstream. Even if they survived digestion, their large size and hydrophilic nature prevent them from crossing the intestinal epithelium efficiently. This is why most peptide drugs require injection, though oral formulations using protective coatings are being developed.

How does the body know when to release peptide hormones?

Peptide hormones are stored in secretory granules and released through regulated exocytosis when the cell receives a specific signal. The most common trigger is an increase in intracellular calcium, which causes granule membranes to fuse with the cell surface. Different hormones have different triggers: glucose stimulates insulin release, GnRH stimulates LH release, and nerve impulses stimulate oxytocin release.

What is C-peptide and why is it released with insulin?

C-peptide is the connecting segment of proinsulin that gets cut out when convertases process proinsulin into mature insulin. Equal amounts of C-peptide and insulin are released together from beta cell granules. Because C-peptide is not cleared as quickly as insulin, measuring blood C-peptide levels reveals how much insulin the pancreas is producing, making it a key diabetes diagnostic tool.